HOME >> MEDICINE >> NEWS
Koo receives IADR Young Investigator Award

The International Association for Dental Research (IADR), convening here today at the Brisbane Convention & Exhibition Centre for its 84th General Session, has awarded the 2006 Young Investigator Award to Dr. Hyun (Michel) Koo, University of Rochester, NY.

Dr. Koo represents the best and brightest of a new generation of young investigators. His work in microbial biofilms represents the cutting edge for dental and oral craniofacial research and shows that the future of dental research is in good hands.

The IADR Young Investigator Award, supported by The Procter & Gamble Co., is designed to stimulate basic research in all dental disciplines. To be eligible for the award, the recipient must not have reached his/her 36th birthday at the time the award is presented. The award consists of a cash prize and plaque.

Dr. Koo receives his award during the Opening Ceremonies of the IADR's 84th General Session. One of 15 Distinguished Scientist Awards conferred annually by the IADR, the award represents the highest honor the IADR can bestow.


'"/>

Contact: Linda Hemphill
lhemphill@iadr.org
International & American Association for Dental Research
28-Jun-2006


Page: 1

Related medicine news :

1. Indiana University Imaging Center receives $6M grant for kidney research
2. FPG receives $8 million for autism research
3. Tony Hunter receives Robert. J. and Claire Pasarow Award for Cancer Research
4. Boston University School of Medicine faculty member receives honorary degree from alma mater
5. UCLA Stroke Center receives American Stroke Associations Initial Achievement Award
6. San Francisco VA researcher receives top Veterans Affairs award
7. Ronald W. Busuttil receives American Surgical Associations highest honor
8. Menzies School of Health Research receives $5.3 million in Federal Budget
9. Who receives a kidney transplant first?
10. UD receives $1.9 million for new spintronics center
11. Margaret Foti receives AACR Award for Leadership and Extraordinary Achievements in Cancer Research

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:7/28/2017)... (PRWEB) , ... July 28, 2017 , ... Kevin Harrington, one of the original Sharks ... announce the launch of a new DRTV campaign with My Real Earth. , Most people ... our bodies is just as important as what we put in our bodies. After all, ...
(Date:7/28/2017)... ... July 28, 2017 , ... For over 20 years Sealy Baby has been ... babies. We take tremendous pride in using some of nature’s best materials while integrating ... and innovative crib mattresses and crib bedding for infants and ...
(Date:7/27/2017)... , ... July 27, 2017 , ... ... through an alliance of independent physicians, has launched a new educational series of ... Jersey’s new regulations governing the prescribing of pain medication. The first two episodes ...
(Date:7/27/2017)... ... July 27, 2017 , ... Patients with ... in a single office visit from Dr. Alejandro Kovacs. Dr. Kovacs is a ... East Texas patients, including Teeth-in-a-Day® dental implants in Longview, TX. ...
(Date:7/27/2017)... , ... July 27, 2017 , ... ... Verification to State Medicaid programs, Managed Care Organizations and Home Care Agencies, has ... The MEDsys platform, VinCENT, provides technology solutions to over 1,000 agencies and multiple ...
Breaking Medicine News(10 mins):
(Date:7/12/2017)... Lilly and Company (NYSE: LLY ) has entered ... patent litigation in the U.S. District Court for the Eastern ... ® (tadalafil) unit dose patent. This patent was previously ... the agreement, Cialis exclusivity is now expected to end at ... dose patent for Cialis is valid and infringed by companies ...
(Date:7/11/2017)...  The global market for liquid biopsy diagnostic and ... in 2016.  Although in early stages, the global market ... as a result of the gradual shift towards personalized ... of a significant number of new liquid biopsy tests ... biomarkers to guide treatment decisions. ...
(Date:7/11/2017)... , July 11, 2017 Oramed Pharmaceuticals ... a clinical-stage pharmaceutical company focused on the development of ... Food and Drug Administration (FDA) has agreed to schedule ... completed Phase IIb trial of its oral insulin capsule ... Phase IIb trial met primary and secondary endpoints by ...
Breaking Medicine Technology:
Cached News: